• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成人白喉、破伤风和百日咳免疫接种

Diphtheria, tetanus, and pertussis immunizations in adults.

作者信息

Edwards K M

机构信息

Vanderbilt University School of Medicine, Nashville, Tennessee.

出版信息

Infect Dis Clin North Am. 1990 Mar;4(1):85-103.

PMID:2407780
Abstract

Although only few cases of diphtheria are reported annually in the United States, substantial numbers of adults have declining levels of protective serum antitoxin. A recent outbreak of diphtheria in Sweden emphasizes the importance of reimmunizing adults in diphtheria toxoid, included as part of routine use of tetanus/diphtheria toxoid. Tetanus is a completely preventable disease. Yet, most of the 60 to 100 annual cases of tetanus occur in older adults with no prior history of immunization. Tetanus immunization should be a routine part of medical care of all adults. Research currently is aimed at improving the efficacy and safety of pertussis vaccine. Future vaccines may be useful in protecting health care workers and other adults who have extensive contact with children against pertussis.

摘要

尽管美国每年仅报告少数几例白喉病例,但大量成年人的保护性血清抗毒素水平在下降。瑞典最近爆发的白喉疫情凸显了对成年人重新接种白喉类毒素的重要性,白喉类毒素是破伤风/白喉类毒素常规使用的一部分。破伤风是一种完全可预防的疾病。然而,每年60至100例破伤风病例中的大多数发生在没有免疫接种史的老年人中。破伤风免疫接种应成为所有成年人医疗保健的常规组成部分。目前的研究旨在提高百日咳疫苗的效力和安全性。未来的疫苗可能有助于保护医护人员和其他与儿童有广泛接触的成年人预防百日咳。

相似文献

1
Diphtheria, tetanus, and pertussis immunizations in adults.成人白喉、破伤风和百日咳免疫接种
Infect Dis Clin North Am. 1990 Mar;4(1):85-103.
2
Diphtheria, tetanus, and pertussis: guidelines for vaccine prophylaxis and other preventive measures. Recommendation of the Immunization Practices Advisory Committee. Centers for Disease Control, Department of Health and Human Services.白喉、破伤风和百日咳:疫苗预防及其他预防措施指南。免疫实践咨询委员会的建议。美国卫生与公众服务部疾病控制中心
Ann Intern Med. 1985 Dec;103(6 ( Pt 1)):896-905.
3
The value of booster vaccinations against diphtheria, tetanus, pertussis and poliomyelitis.白喉、破伤风、百日咳和脊髓灰质炎加强疫苗接种的价值。
J Prev Med Hyg. 2008 Mar;49(1):47-54.
4
Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine in adults aged 65 years and older - Advisory Committee on Immunization Practices (ACIP), 2012.更新的破伤风类毒素、白喉类毒素和无细胞百日咳(Tdap)疫苗在 65 岁及以上成人中的使用建议 - 免疫实践咨询委员会(ACIP),2012 年。
MMWR Morb Mortal Wkly Rep. 2012 Jun 29;61(25):468-70.
5
Immunization against diphtheria, pertussis and tetanus.白喉、百日咳和破伤风免疫接种。
J Okla State Med Assoc. 1969 Mar;62(3):100-2.
6
Tetanus-diphtheria-acellular pertussis vaccination of adults in the USA.美国成年人的破伤风-白喉-无细胞百日咳疫苗接种
Expert Rev Vaccines. 2008 Jul;7(5):621-34. doi: 10.1586/14760584.7.5.621.
7
Experience with diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine in Japan.日本白喉类毒素-破伤风类毒素-无细胞百日咳疫苗的使用经验。
Clin Infect Dis. 1999 Jun;28 Suppl 2:S124-30. doi: 10.1086/515063.
8
An adolescent and adult formulation combined tetanus, diphtheria and five-component pertussis vaccine.一种青少年及成人剂型的破伤风、白喉和五组分百日咳联合疫苗。
Expert Rev Vaccines. 2006 Apr;5(2):175-87. doi: 10.1586/14760584.5.2.175.
9
Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.联合低抗原含量白喉-破伤风-无细胞百日咳和脊髓灰质炎疫苗(dTpa-IPV)用于成人加强免疫接种。
Vaccine. 2005 May 25;23(28):3657-67. doi: 10.1016/j.vaccine.2005.02.013.
10
Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.青少年百日咳的预防:破伤风类毒素、白喉类毒素减少量及无细胞百日咳(Tdap)疫苗的使用建议
Pediatrics. 2006 Mar;117(3):965-78. doi: 10.1542/peds.2005-3038. Epub 2005 Dec 28.

引用本文的文献

1
The immunogenicity and safety of a new combined diphtheria, tetanus and poliomyelitis booster vaccine (Td-eIPV).一种新型白喉、破伤风和脊髓灰质炎联合加强疫苗(Td-eIPV)的免疫原性和安全性。
Infection. 1999 Jan-Feb;27(1):49-56. doi: 10.1007/BF02565175.